Skip to main content

Diabetes

WellDoc receives FDA approval for DiabetesManager System
BALTIMORE WellDoc, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, on Monday announced that it has received Food and Drug Administration 510(k) clearance to market the WellDoc DiabetesManager System to healthcare providers and their adult patients with Type 2 diabetes.
Study: Two therapies may slow diabetic retinopathy in Type 2 diabetes
WINSTON-SALEM, N.C. In high-risk adults with Type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

Bayer Diabetes Care updates devices under National Glycohemoglobin Standardization Program
PositiveID developing breath glucose-detection device
As diabetes rates grow, R&D pipelines flow
Reporters Notebook
Type 1 diabetic women may not benefit from omega-3 consumption

NEW YORK Women with Type 1 diabetes may not necessarily reduce their risk of heart disease if they consume omega-3 fatty acids, according to a University of Pittsburgh Graduate School of Public Health study.
DRSI ReStore! Energy continues retail rollout
Medtronic develops Test B4U Drive program for teens
Biodel receives research grants from JDRF

X

This ad will auto-close in 10 seconds